176 related articles for article (PubMed ID: 32510854)
41. Endoscopic surveillance in patients with multiple (10-100) colorectal polyps.
Valentín F; Guarinos C; Juárez M; Rodríguez-Soler M; Serradesanferm A; Rodriguez-Moranta F; Nicolas-Perez D; Bujanda L; Herraiz M; De-Castro L; Fernández-Bañares F; Herreros-de-Tejada A; Martínez F; Aguirre E; Ferrández Á; Díaz-Tasende J; Piñol V; Paya A; Egoavil C; Alenda C; Castells A; Jover R; Cubiella J
Endoscopy; 2016 Jan; 48(1):56-61. PubMed ID: 26165738
[TBL] [Abstract][Full Text] [Related]
42. Long-term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort.
Bjerrum A; Andersen O; Fischer A; Lindebjerg J; Lynge E
Int J Cancer; 2017 Aug; 141(3):503-511. PubMed ID: 28463410
[TBL] [Abstract][Full Text] [Related]
43. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test.
Meester RG; Zauber AG; Doubeni CA; Jensen CD; Quinn VP; Helfand M; Dominitz JA; Levin TR; Corley DA; Lansdorp-Vogelaar I
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1445-1451.e8. PubMed ID: 27211498
[TBL] [Abstract][Full Text] [Related]
44. Long-term risk of colorectal cancer after screen-detected adenoma: Experiences from a Danish gFOBT-positive screening cohort.
Bjerrum A; Lindebjerg J; Andersen O; Fischer A; Lynge E
Int J Cancer; 2020 Aug; 147(4):940-947. PubMed ID: 31894860
[TBL] [Abstract][Full Text] [Related]
45. Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals With a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus.
Leddin D; Lieberman DA; Tse F; Barkun AN; Abou-Setta AM; Marshall JK; Samadder NJ; Singh H; Telford JJ; Tinmouth J; Wilkinson AN; Leontiadis GI
Gastroenterology; 2018 Nov; 155(5):1325-1347.e3. PubMed ID: 30121253
[TBL] [Abstract][Full Text] [Related]
46. Advances in CRC Prevention: Screening and Surveillance.
Dekker E; Rex DK
Gastroenterology; 2018 May; 154(7):1970-1984. PubMed ID: 29454795
[TBL] [Abstract][Full Text] [Related]
47. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.
Wolf AMD; Fontham ETH; Church TR; Flowers CR; Guerra CE; LaMonte SJ; Etzioni R; McKenna MT; Oeffinger KC; Shih YT; Walter LC; Andrews KS; Brawley OW; Brooks D; Fedewa SA; Manassaram-Baptiste D; Siegel RL; Wender RC; Smith RA
CA Cancer J Clin; 2018 Jul; 68(4):250-281. PubMed ID: 29846947
[TBL] [Abstract][Full Text] [Related]
48. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
[TBL] [Abstract][Full Text] [Related]
49. Risk stratification and detection of new colorectal neoplasms after colorectal cancer screening with faecal occult blood test: experiences from a Danish screening cohort.
Bjerrum A; Milter MC; Andersen O; Fischer A; Lynge E
Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1433-7. PubMed ID: 26352132
[TBL] [Abstract][Full Text] [Related]
50. Post-colonoscopy cancer rate at a tertiary referral hospital in Australia: A data linkage analysis.
Lamba M; Khaing MM; Ma X; Ryan K; Appleyard M; Leggett B; Grimpen F
J Gastroenterol Hepatol; 2023 May; 38(5):740-746. PubMed ID: 36436544
[TBL] [Abstract][Full Text] [Related]
51. [Prevention and early detection of colorectal cancer in average risk population--summary of a meeting and the Israeli gastroenterology policy].
Strul H; Elyakim R; Halpern Z; Arber N
Harefuah; 2003 Mar; 142(3):223-6, 236. PubMed ID: 12696479
[TBL] [Abstract][Full Text] [Related]
52. Causes of Post-Colonoscopy Colorectal Cancers Based on World Endoscopy Organization System of Analysis.
Anderson R; Burr NE; Valori R
Gastroenterology; 2020 Apr; 158(5):1287-1299.e2. PubMed ID: 31926170
[TBL] [Abstract][Full Text] [Related]
53. Optimal age for screening colonoscopy: a modeling study.
Chen C; Stock C; Hoffmeister M; Brenner H
Gastrointest Endosc; 2019 May; 89(5):1017-1025.e12. PubMed ID: 30639539
[TBL] [Abstract][Full Text] [Related]
54. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study.
Samadder NJ; Curtin K; Tuohy TM; Pappas L; Boucher K; Provenzale D; Rowe KG; Mineau GP; Smith K; Pimentel R; Kirchhoff AC; Burt RW
Gastroenterology; 2014 Apr; 146(4):950-60. PubMed ID: 24417818
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of appropriate colorectal cancer screening and preferences for receiving screening advice among people attending outpatient clinics.
Dodd N; Mansfield E; Carey M; Oldmeadow C
Aust N Z J Public Health; 2018 Aug; 42(4):334-339. PubMed ID: 29528551
[TBL] [Abstract][Full Text] [Related]
56. Effect of screening colonoscopy on colorectal cancer incidence and mortality.
Kahi CJ; Imperiale TF; Juliar BE; Rex DK
Clin Gastroenterol Hepatol; 2009 Jul; 7(7):770-5; quiz 711. PubMed ID: 19268269
[TBL] [Abstract][Full Text] [Related]
57. Synthetic indicator of the impact of colorectal cancer screening programmes on incidence rates.
Zorzi M; Zappa M;
Gut; 2020 Feb; 69(2):311-316. PubMed ID: 31040168
[TBL] [Abstract][Full Text] [Related]
58. Options for screening for colorectal cancer in the Royal Air Force: a cost-effectiveness evaluation.
Daniels K; McKee M
J R Army Med Corps; 1995 Oct; 141(3):142-50. PubMed ID: 8568748
[TBL] [Abstract][Full Text] [Related]
59. Effect of colonoscopy on colorectal cancer incidence and mortality: an instrumental variable analysis.
Jacob BJ; Moineddin R; Sutradhar R; Baxter NN; Urbach DR
Gastrointest Endosc; 2012 Aug; 76(2):355-64.e1. PubMed ID: 22658386
[TBL] [Abstract][Full Text] [Related]
60. Survival of patients with symptom- and screening-detected colorectal cancer.
Brenner H; Jansen L; Ulrich A; Chang-Claude J; Hoffmeister M
Oncotarget; 2016 Jul; 7(28):44695-44704. PubMed ID: 27213584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
